CaMKIIα shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemCaMKIIα shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-29900-SH
Quantity20 µg
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Namecalcium/calmodulin dependent protein kinase II alpha
NCBI Gene AliasesCAMKA, CaMKIINalpha, CaMKIIalpha, MRD53, MRT63

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Ca2+/calmodulin-dependent protein kinase II regulates the inflammatory hDPSCs dentino-differentiation via BDNF/TrkB receptor signalingFrontiers in Cell and Developmental BiologyMarch 26, 2025Ji Hyun Kim, Muhammad Irfan, Sreelekshmi Sreekumar, Kerwin Chong, Jin Hong, Satish Alapati, Seung Chung#K5041-1D4), and rabbit anti-DSPP (Santa Cruz, Cat #SA160926LC). siRNA targeting human CaMKII (Cat #sc-29900-SH), siRNA control (Cat #sc-37007), and siRNA Reagent System (Cat #sc-45064) were purchased from Santa Cruz Biotechnology

(2) The mechanism of CaMK2α-MCU-mitochondrial oxidative stress in bupivacaine-induced neurotoxicityFree radical biology & medicineMay 20, 2020Liu Z, Zhao W, Yuan P, Zhu P, Fan K, Xia Z, Xu S.

(3) Inhibition of CaMKIIα Activity Enhances Antitumor Effect of Fullerene C60 Nanocrystals by Suppression of Autophagic DegradationAdvanced science (Weinheim, Baden-Wurttemberg, Germany)April 17, 2019Xu J, Wang H, Hu Y, Zhang YS, Wen L, Yin F, Wang Z, Zhang Y, Li S, Miao Y, et al.

(4) The therapeutic response of CDDO-Me in the esophageal squamous cell carcinoma (ESCC) cells is mediated by CaMKIIαAmerican journal of translational researchJanuary 1, 2016Wang YY, Zhou S, Zhao R, Hai P, Zhe H.

(5) Ca²⁺/calmodulin-dependent protein kinase II mediates platelet-derived growth factor-induced human hepatic stellate cell proliferationDigestive diseases and sciencesApril 1, 2012Ping A, Yihao T, Jingxing D, Minkai C, Hesheng L.

(6) alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progressionLaboratory investigation; a journal of technical methods and pathologySeptember 1, 2007Yuan K, Chung LW, Siegal GP, Zayzafoon M.

Be the First to Write a Review!